These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9988238)

  • 1. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Heep H; Dutkowski P; Willers R; Seeber S; Gabbert HE
    Int J Cancer; 1999 Feb; 84(1):86-91. PubMed ID: 9988238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
    Sarbia M; Stahl M; zur Hausen A; Zimmermann K; Wang L; Fink U; Heep H; Dutkowski P; Willers R; Müller W; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Nov; 4(11):2615-23. PubMed ID: 9829724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.
    Ikeguchi M; Sakatani T; Ueta T; Kaibara N
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):531-6. PubMed ID: 11570573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
    Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
    J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
    Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
    Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 overexpression versus response to induction chemotherapy in squamous cell carcinoma of the head and neck--preliminary report.
    Akervall J; Brun E; Dictor M; Wennerberg J
    Acta Oncol; 2001; 40(4):505-11. PubMed ID: 11504311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma.
    Hou X; Liang RB; Wei JC; Xu Y; Fu JH; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
    Oncotarget; 2016 May; 7(21):31088-96. PubMed ID: 27145270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.
    Shiozaki A; Nakashima S; Ichikawa D; Fujiwara H; Konishi H; Komatsu S; Kubota T; Okamoto K; Iitaka D; Shimizu H; Nako Y; Takemoto K; Kishimoto M; Otsuji E
    Anticancer Res; 2013 Oct; 33(10):4329-35. PubMed ID: 24123000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus.
    Ikeda G; Isaji S; Chandra B; Watanabe M; Kawarada Y
    Cancer; 1999 Oct; 86(8):1396-405. PubMed ID: 10526265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy].
    Zhu S; Zhai F; Yin W
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):129-31. PubMed ID: 10920963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
    Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M
    Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
    Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma.
    Nagasawa S; Onda M; Sasajima K; Makino H; Yamashita K; Takubo K; Miyashita M
    J Surg Oncol; 2001 Nov; 78(3):208-14. PubMed ID: 11745809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
    Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research.
    Pouliquen X; Levard H; Hay JM; McGee K; Fingerhut A; Langlois-Zantin O
    Ann Surg; 1996 Feb; 223(2):127-33. PubMed ID: 8597505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Okamura A; Watanabe M; Mine S; Kurogochi T; Yamashita K; Hayami M; Imamura Y; Ogura M; Ichimura T; Takahari D; Chin K
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients].
    Malhaire JP; Lozac'h P; Simon H; Labat JP; Topart P; Lucas B; Metges JP; Lamezec B
    Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.